Union Square Park Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Union Square Park Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$100K	–	121
2022 Q2	$100K	Hold	10,000	–	–	0.1%	55
2022 Q1	$100K	Buy	+10,000	New	+$99.3K	0.04%	65

Other funds holding IQMD

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Union Square Park Capital Management's IQMD Position: Q3 2022 in Review

Union Square Park Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q3 2022, closing a stake of 10,000 shares — an estimated $100K sold.

Union Square Park Capital Management first reported a position in IQMD in Q1 2022 and held it in 2 quarters. The position peaked at $100K in Q2 2022. 58 funds tracked by Wall St. Rank hold IQMD as of Q3 2022.

Union Square Park Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Union Square Park Capital Management sold 10,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $100K.
Union Square Park Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
Union Square Park Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $100K in Q2 2022.
58 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Union Square Park Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.